Home › Desmoplastic Small Round Cell Tumor
Desmoplastic Small Round Cell Tumor clinical trials recruiting in the U.S.
6 studies for Desmoplastic Small Round Cell Tumor are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Lurbinectedin in FET-Fused Tumors
RecruitingPhase 1/2
Ages 10 and older · All sexes · Updated Sep 2, 2026 · NCT05918640Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Jun 30, 2026 · NCT06625190B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04897321Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
RecruitingPhase 1/2
Ages 12 to 49 · All sexes · Updated Feb 19, 2026 · NCT06709495Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
RecruitingObservational study
All ages · All sexes · Updated Jan 12, 2026 · NCT04690374From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.